Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Krishnan Harinivas Harshan"'
Autor:
Sana Parveen, Dhiviya Vedagiri, Hitha Gopalan Nair, Haripriya Parthasarathy, Krishnan Harinivas Harshan
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Abstract We recently reported an atypical epithelial mesenchymal transition (EMT) in human hepatoma cell culture Huh7.5, which was non-responsive to the canonical EMT-transcription factors. Here we characterize major pathways regulating this atypical
Externí odkaz:
https://doaj.org/article/bc9e9c8636ea40ab9f5d59d854931e02
Autor:
Dhiviya Vedagiri, Divya Gupta, Anurag Mishra, Gayathri Krishna, Meenakshi Bhaskar, Vishal Sah, Anirban Basu, Debasis Nayak, Manjula Kalia, Mohanan Valiya Veettil, Krishnan Harinivas Harshan
Publikováno v:
J Virol
Retinoic acid-inducible gene I-like receptors (RLRs) are important cytosolic pattern recognition receptors (PRRs) that sense viral RNA before mounting a response leading to the activation of type I IFNs. Several viral infections induce epithelial-mes
Autor:
Divya Gupta, Manish Kumar Johri, Krishnan Harinivas Harshan, Hiren Vasantrai Lashkari, Dhiviya Vedagiri
Publikováno v:
Journal of General Virology. 101:86-95
The mechanistic target of rapamycin (mTOR), an important kinase that assimilates several upstream signals, associates into two functional complexes, mTORC1 and mTORC2. In this study, we demonstrate that HCV infection activates mTORC1 that functions i
Autor:
Divya, Gupta, Farhan, Ahmed, Dixit, Tandel, Haripriya, Parthasarathy, Dhiviya, Vedagiri, Vishal, Sah, B, Krishna Mohan, Rafiq Ahmad, Khan, Chiranjeevi, Kondiparthi, Prabhudas, Savari, Sandesh, Jain, Shashikala, Reddy, Jerald Mahesh, Kumar, Nooruddin, Khan, Krishnan Harinivas, Harshan
Publikováno v:
Clinical immunology (Orlando, Fla.). 237
Neutralizing antibody-based passive immunotherapy could be an important therapeutic option against COVID-19. Herein, we demonstrate that equines hyper-immunized with chemically inactivated SARS-CoV-2 elicited high antibody titers with a strong virus-
Autor:
Manjula Kalia, Mohanan Valiya Veettil, Krishnan Harinivas Harshan, Gayathri Krishna, Anurag Mishra, Dhiviya Vedagiri, Meenakshi Bhaskar, Divya Gupta, Vishal Sah, Debasis Nayak, Anirban Basu
Publikováno v:
Journal of Virology. 95
Retinoic acid-inducible gene I-like receptors (RLRs) are important cytosolic pattern recognition receptors (PRRs) that sense viral RNA before mounting a response leading to the activation of type I IFNs. Several viral infections induce epithelial-mes
Autor:
Dhiviya Vedagiri, Haripriya Parthasarathy, Sana Parveen, Divya Gupta, Krishnan Harinivas Harshan, Hitha Gopalan Nair
Regulation of protein translation occurs primarily at the level of initiation and is mediated by multiple signaling pathways, majorly mechanistic target of rapamycin complex 1 (mTORC1), mitogen-activated protein kinases (MAPKs), and the eukaryotic tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ada71be5c6c02dc77fca4f104a473233
https://doi.org/10.1101/2021.08.30.458160
https://doi.org/10.1101/2021.08.30.458160
The relationship of SARS-CoV-2 with the host translation remains largely unexplored. Using polysome profiling of SARS-CoV-2 infected Caco2 cells, we here demonstrate that the virus induces a strong suppression of global translation by 48 hours of inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c6dbbfbe5a78636732d9ec3ee340c05
https://doi.org/10.1101/2021.05.08.443207
https://doi.org/10.1101/2021.05.08.443207
Autor:
Dhiviya Vedagiri, Vishal Sah, Divya Gupta, Haripriya Parthasarathy, Shashikala Reddy, Krishnan Harinivas Harshan, Tandel D
Publikováno v:
Virus Research
Inactivated viral preparations are important resources in vaccine and antisera industry. Of the many vaccines that are being developed against COVID-19, inactivated whole-virus vaccines are also considered effective. β-propiolactone (BPL) is a widel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9d286831a379df944bd4f636b63e58
https://doi.org/10.1101/2021.04.22.441045
https://doi.org/10.1101/2021.04.22.441045
Autor:
Divya Gupta, Farhan Ahmed, Dixit Tandel, Haripriya Parthasarathy, Dhiviya Vedagiri, Vishal Sah, B. Krishna Mohan, Rafiq Ahmad Khan, Chiranjeevi Kondiparthi, Prabhudas Savari, Sandesh Jain, Shashikala Reddy, Jerald Mahesh Kumar, Nooruddin Khan, Krishnan Harinivas Harshan
Publikováno v:
Clinical Immunology. 237:108981
Autor:
Dhiviya Vedagiri, Yogesh Rai, Vijayakumar Chinnadurai, Anant Narayan Bhatt, Sudhir Chandna, Neeraj Kumari, Abhishek Kumar, Krishnan Harinivas Harshan
Publikováno v:
Life Sciences. 295:120411
The COVID-19 pandemic is an ongoing public health emergency of international concern. While a lot of efforts are being invested in vaccinating the population, there is also an emergent requirement to find potential therapeutics to effectively counter